NCT05163561 - Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine | Biotech Hunter

Enrollment

1,072

Participants

Timeline

Start Date

January 9, 2022

Primary Completion Date

April 29, 2023

Study Completion Date

April 29, 2023

Conditions

Poliomyelitis

Interventions

BIOLOGICAL

SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot A

SII Inactivated Salk Polio Vaccine (Adsorbed) produced by Serum Institute of India Pvt. Ltd., is a sterile suspension of three types of inactivated poliovirus: Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett). It is a highly purified, adjuvanted reduced antigen content of inactivated poliovirus vaccine.

BIOLOGICAL

SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot B

SII Inactivated Salk Polio Vaccine (Adsorbed) produced by Serum Institute of India Pvt. Ltd., is a sterile suspension of three types of inactivated poliovirus: Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett). It is a highly purified, adjuvanted reduced antigen content of inactivated poliovirus vaccine.

BIOLOGICAL

SII Inactivated Salk Polio Vaccine (Adsorbed) - Lot C

SII Inactivated Salk Polio Vaccine (Adsorbed) produced by Serum Institute of India Pvt. Ltd., is a sterile suspension of three types of inactivated poliovirus: Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett). It is a highly purified, adjuvanted reduced antigen content of inactivated poliovirus vaccine.

BIOLOGICAL

Sii Licensed IPV

Poliomyelitis Vaccine (Inactivated), produced by Serum Institute of India Pvt. Ltd., is a sterile suspension of three types of inactivated poliovirus: Type 1 (Mahoney), Type 2 (MEF-1), and Type 3 (Saukett). Poliomyelitis Vaccine (Inactivated) is a highly purified, inactivated poliovirus vaccine.

Trial Locations (1)

128

International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), Dhaka